Glutamine and cancer: cell biology, physiology, and clinical opportunities.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23999442.
- Also identified by DOI 10.1172/JCI69600 and PMC identifier 3754270.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Glutamine is an abundant and versatile nutrient that participates in energy formation, redox homeostasis, macromolecular synthesis, and signaling in cancer cells. These characteristics make glutamine metabolism an appealing target for new clinical strategies to detect, monitor, and treat cancer. Here we review the metabolic functions of glutamine as a super nutrient and the surprising roles of glutamine in supporting the biological hallmarks of malignancy. We also review recent efforts in imaging and therapeutics to exploit tumor cell glutamine dependence, discuss some of the challenges in this arena, and suggest a disease-focused paradigm to deploy these emerging approaches.
Medical subject headings
- Biomarkers, Tumor
- Glutamine
- Neoplasms